Start Codon
Overview
Start Codon is a venture capital fund and accelerator that seeks to invest in disruptive healthcare and life science companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Enhanced Genomics | Mar 2021 | Seed | Co-investor |
| Semarion | Mar 2026 | VC Round | Co-investor |
| NK:IO | Oct 2024 | Seed | Co-investor |
| ArkVax | Dec 2022 | Seed | Lead |
| RevoNA Bio | - | Pre Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Start Codon based?
Start Codon is headquartered in Cambridge, United Kingdom.
When was Start Codon founded?
Start Codon was founded in 2019.
How many portfolio companies does Start Codon have?
Start Codon has 11 portfolio companies in Caplight's dataset.
What are some companies in Start Codon's portfolio?
Portfolio companies visible on Caplight include Enhanced Genomics, Semarion, NK:IO, ArkVax, RevoNA Bio.
What was Start Codon's most recent investment shown here?
Start Codon's most recent investment in this portfolio sample was in Semarion in 2026.
What sectors does Start Codon focus on?
Start Codon focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Start Codon focus on?
Start Codon typically invests at the Early stage.
What is Start Codon's AUM?
Start Codon's assets under management are estimated between $20.0M and $20.0M.